Design of ortho/meta-substituted selective carbonic anhydrase IX inhibitors

  • Mantas Žvirblis
  • Vaida Paketurytė-Latvė
  • Marius Gedgaudas
  • Darius Lingė
  • Ernestas Urniežius
  • Tautvydas Kojis
  • Laimonas Stančaitis
  • Audrius Zakšauskas
  • Aurelija Mickevičiūtė
  • Jelena Jachno
  • Vaida Juozapaitienė
  • Virginija Dudutienė
  • Asta Zubrienė
  • Daumantas Matulis
Keywords: protein–ligand binding, binding thermodynamics, recombinant proteins, drug design and synthesis, enzyme inhibition, carbonic anhydrase

Abstract

In the search for chemical compounds that strongly and selectively bind and inhibit one out of 12 catalytically active CA isozymes, a series of fluorinated substituted benzenesulfonamides was designed and synthesised. Substituents were intended to be stiff and have a limited conformational flexibility. We determined compound affinities using the fluorescence-based thermal shift assay. Afterward, we subtracted the binding-linked protonation reactions and calculated the intrinsic affinities, which were then used to establish the structure–affinity relationships. Compound 5 (2-(cyclohexylamino)-3,5,6-trifluoro-4-(phenylsulfonyl) benzenesulfonamide) exhibited an improved selectivity profile toward CAIX, a cancer-associated isozyme. The analysis of compound functional group contributions and the comparison with previously designed compounds provided insight toward a deeper understanding of the protein–ligand recognition principles for drug design.

Published
2026-03-25
Section
Physical Biochemistry